NLS PR Industry

PR Industry - February 4, 2024

Ashfield Nordic has become Inizio Engage Nordic

In June 2023 Ashfield Nordics became Inizio Engage Nordic. A purpose-built brand, set to change the way the industry interacts with its customers, Inizio Engage now combines the strength, expertise, and proven track record of Ashfield Engage and The Creative Engagement Group into a unified global strategic, commercial, and creative engagement partner. Inizio Engage was […]

PR Industry - October 9, 2023

Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing

Houston, Texas – October 9th, 2023 — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, […]

PR Industry - September 6, 2023

Announcing Scandinavian CRO’s new Chairman of the Board 

Scandinavian CRO (SCRO) is a full-service contract research organization that helps industry and academia develop medicines and medical devices that improve patient health. For over 15 years, Founder & CEO Ulrika Hammarström has focused on building a sustainable company with a strong company culture and value-based leadership. As a two-time winner of the Gasell from […]

PR Industry - August 17, 2023

SSI Strategy and NDA Group Combine to Form Best-in-Class Global Life Sciences Consultancy

On Tuesday, 15th of August, NDA Group and SSI Strategy announced the merger of their companies, creating an industry leading life sciences consulting firm. This collaboration combines two trusted consultancies to provide end-to-end support for drug development companies, guiding them from concept to commercialization. SSI Strategy brings exceptional medical, clinical, and development expertise to complement NDA’s regulatory capabilities. Their teams, […]

PR Industry - August 7, 2023

Antibody-drug Conjugates: A Novel Paradigm for Cancer Therapy

Chemotherapy is one of the most widely used cancer therapies; however, chemotherapy often causes serious side effects. Antibody-drug conjugates (ADCs) are promisingly emerging cancer therapies that combine the effective killing power of small molecule cytotoxins and the highly specific targeting ability of monoclonal antibodies (mAbs). Thus, ADCs precisely deliver cytotoxins to tumor cells, while minimally […]

PR Industry - June 28, 2023

The new era of bispecific antibodies for cancer immunotherapy

Emerging bispecific antibodies and their targets in cancer immunotherapy in the discovery, development, preclinical, and clinical stages. Monoclonal antibodies have revolutionized cancer therapy since their introduction as therapeutics in the field. To enhance the specificity and potency of antibodies, bispecific antibodies (bsAbs) are emerging, with the ability to bind two different antigens or two different […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.